𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1.076 PREDISPOSING FACTORS FOR COGNITIVE IMPAIRMENT IN PARKINSON'S DISEASE: ASSESSMENT OF 67 PATIENTS

✍ Scribed by G.S. Dahani; M. Al-Hakami; A. Dahani; Z. Waheed; B. Hameed

Book ID
117754561
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
70 KB
Volume
18
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cognitive impairment in Parkinson's dise
Cognitive impairment in Parkinson's disease: Tools for diagnosis and assessment
✍ Jaime Kulisevsky; Javier Pagonabarraga πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 1 views

## Abstract Cognitive impairment (CI) and dementia are frequent and debilitating features associated with Parkinson's disease (PD). Formal neuropsychological examination is required to ascertain the degree and pattern of CI over the course of the disease. The use of different tools may explain hete

Risk factors for Parkinson's disease and
Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease
✍ Andrew Siderowf; Danna Jennings; James Connolly; Richard L. Doty; Kenneth Marek; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 1 views

## Abstract Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in first‐degree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Id

The montreal cognitive assessment as a s
The montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease
✍ David J. Gill; Arielle Freshman; Jennifer A. Blender; Bernard Ravina πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 75 KB

## Abstract Cognitive impairment is common in Parkinson's disease (PD) and can occur early in the disease course. No effective screening test exists for detection of early or mild cognitive impairment in PD. We examined the Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive dysf